In addition, Chu et al. used bioinformatics techniques combined with clinical data to analyze the expression of thrombospondin-2 (TSP2) in GC tissues and its correlation with clinicopathological features and clinical prognosis of GC patients, indicating that TSP2 is a potential marker and therapeutic target for the prognosis of GC patients. This evidence concerns the gene THBS2 and gastric cancer.